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To validate the bELISA, samples from eastern long-billed corellas (Cacatua 1 tenuiostris) that were part of an experiment to assess a recombinant BFDV 2 capsid protein-based vaccine (Bonne et al., 2008 , Stewart et al., 2007 were 3 tested using the optimised bELISA assay. Samples of blood and serum or 4 plasma, as described above, were taken from vaccinated (n = 15) and non-5 vaccinated control (n = 5) birds on 8 separate occasions, including the time of 6 vaccination and the time of challenge with live virus. In total, 160 samples 7 were thus collected. In addition, samples from 82 cockatiels known to be HI 8 negative (Shearer et al., 2008a) were included to evaluate the diagnostic 9 specificity of the test. Samples included both dried blood on filter paper and 10
plasma. 11 12
For blood collected onto filter paper, two 6mm diameter spots of blood on filter 13 paper were excised using either scissors or a hole punch and placed into a 14 microcentrifuge tube (Eppendorf, Hamburg, Germany). One hundred 15 microlitres of ELISA blocking buffer (PBS, 0.05% (v/v) Tween 20, 5% (w/v) 16 skim milk powder (Fonterra Foodservices, North Ryde, Australia)) was then 17 added in order to make a 1:5 (w/v) suspension and serum eluted from the 18 paper by incubating the mixture for 1 hour at room temperature. Serum or 19 plasma samples were diluted 1:5 in blocking buffer. 20 21
Production of recombinant BFDV capsid protein

22
A full-length, baculovirus-expressed BFDV capsid protein was expressed and coat at 4ºC overnight. The plate was then washed with wash buffer, blocking 7 buffer added to all wells and the plate incubated for 1 hour at room 8 temperature. After another wash step, 50 μL of blocking buffer was added to 9 all wells of the ELISA plate. Then 50 μL sera from each of the 5 psittacine 10 birds described above, eluted as previously described, was added to the first 11 well of each row and serially diluted across the plate. The plate was then 12 incubated for 1 hour at room temperature. After removing the sera, the plate 13 was washed again and 50 μL/well of a monoclonal antibody against the 14 recombinant BFDV capsid protein , diluted 1:400 in blocking buffer, was 15 added and the plate incubated for 1 hour at room temperature. After washing, tested using the optimised bELISA. Samples included both dried blood on 8 filter paper and plasma. After testing, the PI of the samples were compared to 9 the corresponding HI titres. In addition, samples from 82 cockatiels that had 10 been assessed as negative by HI (Shearer et al., 2008a) were also tested 11 using the optimised bELISA. 12
13
For blood collected onto filter paper one spot of blood on filter paper was cut 14 out using scissors or hole punch and collected into a microcentrifuge tube 15 (Eppendorf, Hamburg, Germany). 100 μL of ELISA blocking buffer was then 16 added (to make a 1:10 (w/v) suspension) and serum eluted from the paper by 17 incubating the mixture for 1 hour at room temperature. Serum or plasma 18 samples were diluted 1:10 in blocking buffer. 19
20
Tests to evaluate the precision, repeatability and accuracy of the assay were 21 also conducted; however it was not practical to evaluate reproducibility 22 between laboratories. Repeatability assays were conducted using pooled sera 23 from 10 vaccinated birds. The intra-assay coefficient of variation was 24 determined by performing 10 replicates of pooled sera and the inter-assay 25 A c c e p t e d M a n u s c r i p t 9 coefficient of variation was determined by repeating this group of replicates 10 1 times. Data from the assay of intra-assay repeatability was plotted to 2 determine the assay's precision. The linearity of the assay was also 3 investigated using 10 replicates of the pooled sera that were serially diluted 4 1:2 and the PI values plotted against the log 2 of the dilution factor. 5 6 3 Results 
Indirect Enzyme-Linked Immunosorbent Assay
8
The optimal amount of protein used in the indirect ELISA was determined to 9 be 250ng/well and the optimal dilution of monoclonal antibody was 1:400. The 10 indirect ELISA performed well at many other combinations of protein and 11 monoclonal antibody dilution, but the above protein amount and antibody 12 dilution were selected as they had a good positive absorbance value and a 13 useful dynamic range. dilution of these sera for use in the bELISA was determined to be 1:10. This 21 gave a useful dynamic range and a lower limit of detection (greater analytical 22 sensitivity) than the HI test. A c c e p t e d M a n u s c r i p t All cockatiels that tested negative by HI were also negative by bELISA. The 1 corellas vaccinated with the recombinant protein had peak mean PI levels of 2 between 6.01% and 44.26% at challenge (after the second vaccination) and 3 between 62.43% and 90.22% after challenge with live virus (Figure 1 ). Non-4 vaccinated control birds had peak antibody levels of between 55.25% and 5 83.26% after challenge with live virus. Importantly, although the samples from 6 birds vaccinated with the recombinant protein were HI-negative at the time of 7 the second vaccination, the bELISA detected low levels of antibodies in these 8 samples. The correlation coefficient between antibody levels measured by 9 bELISA and HI titres was high (r 2 = 0.8156, p<0.05) (Figure 2 ). Based on the 10 results of the vaccine trial samples only, sensitivity was 99.09% and specificity 11 was 71.43% when compared to the HI assay, with a positive and negative 12 predictive value of 87.2% and 97.56% respectively. Using the results of the 13 cockatiel sero-survey, the bELISA was 100% specific and combining these 14 results with the results of the vaccine trial gave the same sensitivity and 15 increased the specificity to 88.41% and the negative predictive value to 16 99.19%. The mean PI value of the pooled sera was 64.28% and almost all 17 repeated samples fell within ± 2 standard deviations of the mean value 18 (Figure 3a) . The intra-and inter-assay coefficients of variation were 3.61% 19 and 6.94%, respectively and the bELISA was determined to be linear within 20 the working range of the samples tested (Figure 3b) . 
2004) 10 11
The sensitivity and specificity of the blocking ELISA developed in this study 12
were within values defined as acceptable by the OIE (Jacobson, 2004) and 13 should prove to be a useful diagnostic test for BFDV. The analytical sensitivity 14 was greater than the HI test, as it detected antibodies in vaccinated birds that 15
were HI negative and the comparative diagnostic sensitivity and specificity 16 was good. However, because of the greater analytical sensitivity of the 17 bELISA, the absolute diagnostic sensitivity and specificity is likely to be 18 higher. Given the calculated diagnostic sensitivity, 160 samples is adequate to 19 validate the assay with 95% confidence of an accurate result (Jacobson, 20 1998). However, assuming the highest calculated diagnostic specificity of 21 88%, the number of known negative animals required is 1 014. The actual 22 number of known negative animals required is likely to be much less, since 23 the actual diagnostic specificity is likely to be higher. Since it is so difficult to 24
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3
The precision, repeatability and accuracy of the assay were within values 4 accepted by the OIE (Jacobson, 1998) . The cut-off value was determined 5 from a 95% confidence interval of the negative control wells (Coligan et al., 6
2001) since it was almost impossible to find a group of birds known to be truly 7 seronegative. Assuming, though, that the cockatiels were truly seronegative, 8 the cut-off value calculated from a 95% confidence interval of the mean PI of 9 those 82 samples was similar to that calculated using the negative control 10 wells only. As more samples are tested using this assay, the methods of 11 calculating a cut-off value can be compared with receiver-operator curves to 12 see which method is more appropriate. The positive and negative predictive 13 values were good and given the high seroprevalence of BFDV, should 14 translate well to samples from naturally infected birds. This difference means that although the correlation coefficient was high no 22 direct inference between bELISA PI values and HI titres can be made as each 23 HI end-point titre can be associated with a range of bELISA PI values ( Figure  24 2). Thus, the bELISA is the preferred antibody test, as it allows more preciseM a n u s c r i p t characterisation of antibody levels. The intra-and inter-assay coefficients of 1 variation were good and in line with OIE assay validation guidelines 2 (Jacobson, 2004) . Absorbance values fell within the linear range of the assay 3 for the samples tested, however evaluation of the assay's behaviour for 4 samples with PI values greater than 64.28% was not possible. 5
6
Only one other ELISA has been developed to test for the presence of anti-7 BFDV antibodies in psittacine sera (Johne et al., 2004) . This was an indirect 8 ELISA, utilising a truncated recombinant BFDV capsid protein and a 9 secondary antibody directed against psittacine IgY. This ELISA tested 11 10 serum samples from 7 different psittacine species and thus has yet to be 11 validated with a large number of samples of birds with known antibody status. 12
Additionally, no studies have yet been conducted investigating the cross-13 reactivity of psittacine IgY and given that there are 78 genera and 332 species 14 within the Psittacidae, such studies may be prohibitively difficult. This means, 15
though, that a sample from a rare species of psittacine bird which tested 16 negative by indirect ELISA could not be guaranteed to be truly negative. 17
Consequently, we believe that a blocking ELISA, as described in this article, is 18 likely to be a more reliable diagnostic test. The blocking ELISA also has the 19 advantage that serum containing both IgM and IgY can be reliably tested 20 using the one assay, as it does not rely on secondary antibodies directed 21 against either class of immunoglobulin. 22
23
Although the ELISA described in this article has been tested with sera from 6 24 different species of psittacine birds and validated with 160 samples, furtherM a n u s c r i p t testing is necessary to ensure that the assay performs well with sera from as 1 many species of psittacine birds as possible. Any potential problems with 2 consistency of the test between species would theoretically be the result of 3 differing cross-reactivities between the test serum and the recombinant 4 protein. Stewart et al. (2007) failed to find any differences in cross reactivity 5 between the recombinant protein and a number of psittacine anti-BFDV 6 antisera in both western blotting and HI. Additionally, cross-reactivity work 7 using sera from rainbow lorikeets, short-billed corellas, a sulphur-crested 8 cockatoo, a red lory (Eos bornea) and a galah-corella hybrid and virus from 9 rainbow lorikeets, a red lory, two swift parrots (Lathamus discolor), a sulphur-10 crested cockatoo and a scarlet-chested parrot (Neophema splendida) failed to 11 find evidence of antigenic serotypes (Khalesi et al., 2005) . However, a similar 12 experiment using sera from the above birds and virus eluted from the feather 13 of a cockatiel found that sera from some of the birds did not inhibit 14 agglutination by the cockatiel isolate, suggesting that the cockatiel isolate may 15 be sufficiently different antigenically to be considered a separate serotype 16 (Shearer et al., 2008a) . 17
18
The monoclonal antibody used in this study recognised BFDV from a 19 cockatiel, sulphur-crested cockatoo and a rainbow lorikeet (Shearer et al., 20 2008b ). This indicates that there is some antigenic homology between 21
isolates, even if the cockatiel BFDV isolate is indeed a separate serotype. 22
Whilst it is possible that the epitope detected by this monoclonal antibody is 23 not present in some BFDV isolates, the fact that no serotypes have been 24 discovered to date suggests that enough major epitopes should be conservedM a n u s c r i p t between isolates that polyclonal anti-BFDV sera will react with the 1 recombinant protein. Bound sera will thus block the monoclonal antibody from 2 binding, even if the test serum does not react with the exact epitope detected 3 by the monoclonal antibody. Thus, the bELISA should be reliable for use with 4 sera from many species of psittacine birds, unless experimental evidence 5 comes forth that novel BFDV serotypes exist or that the epitope detected by 6 the monoclonal antibody is not immunodominant. Answers to questions about 7 the existence of a cockatiel-adapted BFDV serotype and the relative infectivity 8 and antigenic characteristics of various virus isolates remain to be discovered. 9
These answers may only be found by conducting HI assays using sera from 10 many cockatiels, tested against virus eluted from the feathers from a range of 11 psittacine birds. 12
13
The bELISA has a number of advantages over the HI test. First and most 14 importantly, the bELISA is much more easily standardised as the amounts of 15 both the recombinant protein and monoclonal antibody used in the assay can 16 be quantified more accurately. Even though both the recombinant protein and 17 monoclonal antibody are initially expensive to develop and produce, they are 18 a much more reliable and consistent source of reagents than the virus 19 preparation, polyclonal antibodies and erythrocytes used in HI assays. Virus 20 used in the HI assay must be purified from the feathers from persistently 21 antibody is directly conjugated to HRP. However, the effect of these 10 modifications on assay performance would need to be assessed. The bELISA 11 could also be adapted for the performance of cross-reactivity assays; however 12 possible differences in affinity of the monoclonal antibody for the different 13 virus samples used as antigen in the assay would need to be determined and 14 taken into account. 15 16 Overall, the bELISA described in this paper should be a useful tool for the 17 sero-diagnosis of BFDV infection. It is more readily standardised, simpler to 18 perform, more repeatable and has a greater analytical sensitivity than the HI 19 assay. In the future it should also provide valuable information in subsequent 20 studies on the pathophysiology of the virus, such as the fluctuations in 21 antibody levels at various stages of disease and the transfer of maternal 22 antibodies and their effect on infection and immunity. In this experiment it was 23 able to provide the valuable information that the vaccinated corellas had 24 developed antibodies against the recombinant protein after the firstM a n u s c r i p t vaccination and it should also prove to be very useful in the further 1 optimisation of BFDV vaccination protocols. Vaccinations are indicated by an arrow (↑) and challenge with a triangle (∆).
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Bars indicate standard error. 
